Sign in

CIK 0001337013

  • Accelerated filer
  • Smaller reporting company

InfuSystem Holdings, Inc

Sign in to watch
Ticker
INFU
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203341405
Phone
+1 248-291-1210
Business address
3851 WEST HAMLIN ROAD, ROCHESTER HILLS, MI, 48309
Former names
HAPC, Inc., Healthcare Acquisition Partners Corp.
  1. 4 Grant or award Chief Operating Officer acquired 6,666 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 13,333 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award Chief Executive Officer acquired 16,666 shares (grant or award)
  6. 4 Open-market buy Chief Executive Officer bought 15,100 shares at an average $2.73 ($41,170)
  7. 4 Open-market buy Chief Executive Officer bought 3,669 shares at $2.65 ($9,723)
  8. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $2.75 ($27,500)
  9. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $2.69 ($26,900)
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Shares withheld for taxes Director gave up 39,061 shares (to pay taxes)
  13. 4 Open-market buy Chief Executive Officer bought 15,000 shares at $2.75 ($41,250)
  14. 4 Open-market buy Chief Executive Officer bought 12,750 shares at $2.79 ($35,573)
  15. 4 Open-market buy Chief Executive Officer bought 7,262 shares at an average $2.79 ($20,261)
  16. 4 Open-market buy Chief Executive Officer bought 11,172 shares at an average $2.71 ($30,253)
  17. 4 Derivatives Options or other derivatives
  18. 4/A Shares withheld for taxes Director gave up 44,622 shares (to pay taxes)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 19 of 25 · 489 filings